Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of Intra-Articular Tranexamic Acid in Reducing Early Postoperative Swelling and Pain Following Arthroscopic ACL Reconstruction: A Randomized Comparative Study.

The journal of knee surgery·2026

Same author

An Atypical Presentation of Guillain-Barré Syndrome: Bilateral Facial Nerve Palsy With Preserved Reflexes.

Cureus·2026

Same author

Correction: Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.

The Journal of biological chemistry·2025

Same author

Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up.

Journal of endourology·2025

Same author

Designing effective scenario-based multiple-choice questions for health professionals.

The National medical journal of India·2025

Same author

Curriculum Innovation: Integrating Case-Based Learning With Seminar and Journal Club to Enhance Critical Thinking Skills in Residency Program.

Neurology. Education·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Malignancy in kidney transplant recipients.

¹Department of Surgery, McMaster University, Hamilton, Ontario, Canada. kapoor4@mcmaster.ca

|June 24, 2008

Summary

Kidney transplant patients face a high risk of malignancy due to immunosuppression. Mammalian target of rapamycin (mTOR) inhibitors show promise in reducing cancer incidence post-transplant compared to calcineurin inhibitors (CNIs).

Area of Science:

Nephrology
Oncology
Immunology

Background:

Post-transplant malignancy is a significant cause of morbidity and mortality in kidney transplant recipients.
The risk of malignancy increases with prolonged exposure to immunosuppressive therapy.
Calcineurin inhibitors (CNIs) are associated with an elevated risk of post-transplant cancers.

Purpose of the Study:

To evaluate the role of mammalian target of rapamycin (mTOR) inhibitors in mitigating malignancy risk after kidney transplantation.
To compare the incidence of new malignancies in patients treated with mTOR inhibitors versus CNIs.
To explore the dual immunosuppressive and antineoplastic properties of mTOR inhibitors.

Main Methods:

Review of clinical studies comparing immunosuppression strategies in kidney transplant recipients.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Related Experiment Videos

Last Updated: Jul 5, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Mouse Kidney Transplantation: Models of Allograft Rejection

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

Analysis of data on the incidence of new malignancies in patients receiving mTOR inhibitors versus CNIs.

Examination of experimental and clinical evidence for the antitumour activity of sirolimus and its analogues.

Main Results:

Clinical studies indicate a lower incidence of new malignancies in kidney transplant recipients treated with mTOR inhibitors compared to CNIs.
Sirolimus, an mTOR inhibitor, demonstrates both immunosuppressive and antineoplastic effects.
Newer mTOR inhibitors like temsirolimus are under investigation for their anticancer potential.

Conclusions:

Mammalian target of rapamycin (mTOR) inhibitors represent a promising therapeutic strategy to reduce cancer risk in kidney transplant recipients.
Utilizing mTOR inhibitors in therapeutic protocols may offer protection against allograft rejection while simultaneously addressing cancer concerns.
Further research into mTOR inhibitors and their analogues is warranted for managing post-transplant malignancy.